← Back to headlines
Biotech Company Misses 77% Surge on Gilead Takeover Deal
A biotech company's $64 million exit reportedly missed a significant 77% one-day surge following a takeover deal by Gilead, indicating a potential miscalculation in the timing of the transaction.
16 Mar, 23:33 — 16 Mar, 23:33
Sources
Showing 1 of 1 sources
